Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Zelman & Assoc Initiates Coverage On Ferguson with Buy Rating

Zelman & Assoc initiates coverage on Ferguson (NYSE:FERG) with a Buy rating.

byBenzinga Newsdesk

December 1, 2022

1 minute read

Zelman & Assoc initiates coverage on Ferguson (NYSE:FERG) with a Buy rating.

Morgan Stanley Maintains Equal-Weight on BOK Financial, Raises Price Target to $102

By Benzinga Newsdesk

Today, 9:33 AM

Morgan Stanley analyst Ken Zerbe maintains BOK Financial (NASDAQ:BOKF) with a Equal-Weight and raises the price target from $100 to $102.

BOKF

Morgan Stanley Maintains Equal-Weight on Apollo Global Management, Raises Price Target to $61

By Benzinga Newsdesk

Today, 9:33 AM

Morgan Stanley analyst Michael Cyprys maintains Apollo Global Management (NYSE:APO) with a Equal-Weight and raises the price target from $60 to $61.

APO

AstraZeneca Bets On UK Listed Firm For Lung Diseases

By Vandana Singh

Today, 9:33 AM

Drug Discovery company C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca plc (NASDAQ:AZN) worth up to $402…

AZN

Biden, Putin Discuss Looming Threat Of Ukraine Invasion By Russia: What You Need To Know

By Michael Cohen

Today, 9:33 AM

President Joe Biden spoke with President Vladimir Putin of Russia via video link Tuesday morning amid concerns that Russia is planning to exercise military action against Ukraine.

SPY

Zelman & Assoc Initiates Coverage On Ferguson with Buy Rating

Related Posts

Morgan Stanley Maintains Equal-Weight on BOK Financial, Raises Price Target to $102

Morgan Stanley Maintains Equal-Weight on Apollo Global Management, Raises Price Target to $61

AstraZeneca Bets On UK Listed Firm For Lung Diseases

Biden, Putin Discuss Looming Threat Of Ukraine Invasion By Russia: What You Need To Know